Form CORRESP - Correspondence:
SEC Accession No. 0001628280-17-012740
Filing Date
2017-12-29
Accepted
2017-12-29 17:00:48
Documents
1

Document Format Files

Seq Description Document Type Size
1 filename1.htm CORRESP 15996
  Complete submission text file 0001628280-17-012740.txt   16854
Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000
Type: CORRESP
SIC: 2834 Pharmaceutical Preparations